18. 脊髄小脳変性症（多系統萎縮症を除く。） Spinocerebellar degeneration Clinical trials / Disease details

臨床試験数 : 71 / 薬物数 : 99 - (DrugBank : 30) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 65

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-000282-37-IT (EUCTR)	26/02/2020	17/06/2021	Riluzole in spinocerebellar ataxia type 7	Riluzole(Glentek) in patients with SpinoCerebellar Ataxia type 7: a randomized, double-blind, placeb ...	Spinocerebellar ataxia type 7 (SCA7) MedDRA version: 20.0;Level: SOC;Classification code 10029205;Te ...	Trade Name: Glentek 50 mg film-coated tablets Product Name: Glentek 50 mg compresse rivestite con fil ...	DIPARTIMENTO DI NEUROSCIENZE SALUTE MENTALE E ORGANI DI SENSO - NESMOS - SAPIENZA UNIVERSITÀ DI ROMA ...	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	34	Phase 2	United States;Italy
2	NCT03660917 (ClinicalTrials.gov)	January 1, 2019	15/5/2018	Riluzole in Patients With Spinocerebellar Ataxia Type 7	Riluzolein Patients With Spinocerebellar Ataxia Type 7: a Randomized , Double-blind, Placebo-control ...	SCA7	Drug: Riluzole;Drug: Placebo	S. Andrea Hospital	NULL	Not yet recruiting	7 Years	N/A	All	34	Phase 2/Phase 3	Italy
3	EUCTR2017-001481-23-FR (EUCTR)	12/09/2017	30/10/2017	NA	MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED CLINICAL TRIAL WITH RILUZOLEIN SPINOCEREBE ...	SCA2 patients, both gender, at least 18 years of age MedDRA version: 20.0;Level: PT;Classification c ...	Trade Name: Riluzole PMCS Product Name: Riluzole PMCS INN or Proposed INN: Riluzole Other descriptive nam ...	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)	NULL	Not Recruiting			Female: yes Male: yes	50	Phase 3	France

First Previous1Next Last